| Literature DB >> 12115 |
Abstract
Labetalol (AH5158) a new alpha- and beta-adrenergic blocking agent was given to 12 hypertensive patients for an average of 7 months. Statistically significant and clinically relevant reductions of blood pressure both in the recumbent and standing positions were observed. Side effects were few and the absence of postural hypotension was noted.Entities:
Mesh：
Substances：
Year: 1976 PMID： 12115
Source DB: PubMed Journal: Int J Clin Pharmacol Biopharm ISSN： 0340-0026